கேம்பிரிட்ஜ் அறிவியல் பூங்கா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(0) Follow-on investment, led by Epidarex Capital, closes at £4.24m, following initial £3.2m Seed round in 2020; Caribou Property joins as new investor Management appointments expand leadership team: Dr Steve Myatt, ex Azeria Therapeutics, to Chief Executive Officer; Dr Carola Ries, ex Roche, to Chief Scientific Officer; Co-founder Dr Luca Cassetta to move from his academic role at Edinburgh University to join as full-time VP Immunology Funds will accelerate macrophage-based therapeutics R&D portfolio and target discovery capability; expansion of facilities in Edinburgh and Cambridge Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, announces today that it has closed a follow-on financing of £4.24 million from its 2020 Seed round, bringing the total amount raised to £7.44m.

United statesUnited kingdomCity ofSue charlesJeffrey pollardLuca cassettaKostenloser wertpapierhandelElizabeth roperSteve myattJan robertsonGeorges aboudCaribou propertyNature communicationsCentre for reproductive healthBoston pharmaceuticalsUniversity of edinburgh